SC 13G | 2024-02-14 | T. Rowe Price Investment Management, Inc. | IONIS PHARMACEUTICALS INC | 13,201,453 | 9.2% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | IONIS PHARMACEUTICALS INC | 14,203,481 | 9.9% | EDGAR |
SC 13G/A | 2024-02-13 | BB BIOTECH AG | IONIS PHARMACEUTICALS INC | 8,590,000 | 6.0% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | IONIS PHARMACEUTICALS INC | 21,520,872 | 15.0% | EDGAR |
SC 13G/A | 2024-01-26 | BlackRock Inc. | IONIS PHARMACEUTICALS INC | 9,057,282 | 6.3% | EDGAR |
SC 13G/A | 2023-06-09 | VANGUARD GROUP INC | IONIS PHARMACEUTICALS INC | 14,414,917 | 10.1% | EDGAR |
SC 13G/A | 2023-02-14 | BB BIOTECH AG | IONIS PHARMACEUTICALS INC | 9,635,000 | 6.8% | EDGAR |
SC 13G | 2023-02-14 | T. Rowe Price Investment Management, Inc. | IONIS PHARMACEUTICALS INC | 11,678,259 | 8.2% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | IONIS PHARMACEUTICALS INC | 21,307,519 | 15.0% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | IONIS PHARMACEUTICALS INC | 13,546,694 | 9.5% | EDGAR |
SC 13G/A | 2023-02-01 | BlackRock Inc. | IONIS PHARMACEUTICALS INC | 9,182,911 | 6.5% | EDGAR |
SC 13G/A | 2022-08-10 | PRICE T ROWE ASSOCIATES INC /MD/ | IONIS PHARMACEUTICALS INC | 4,808,770 | 3.3% | EDGAR |
SC 13G/A | 2022-04-11 | PRICE T ROWE ASSOCIATES INC /MD/ | IONIS PHARMACEUTICALS INC | 14,350,460 | 10.1% | EDGAR |
SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | IONIS PHARMACEUTICALS INC | 12,490,280 | 8.8% | EDGAR |
SC 13G/A | 2022-02-11 | BB BIOTECH AG | IONIS PHARMACEUTICALS INC | 10,232,973 | 7.2% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | IONIS PHARMACEUTICALS INC | 12,007,076 | 8.5% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | IONIS PHARMACEUTICALS INC | 21,181,502 | 15.0% | EDGAR |
SC 13G | 2022-02-09 | ARK Investment Management LLC | IONIS PHARMACEUTICALS INC | 7,083,256 | 5.0% | EDGAR |
SC 13G | 2022-02-01 | BlackRock Inc. | IONIS PHARMACEUTICALS INC | 8,539,282 | 6.0% | EDGAR |
SC 13G | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | IONIS PHARMACEUTICALS INC | 13,114,967 | 9.3% | EDGAR |